Canonical WNT pathway is activated in the airway epithelium in chronic obstructive pulmonary disease
François M. Carlier,
Sébastien Dupasquier,
Jérôme Ambroise,
Bruno Detry,
Marylène Lecocq,
Charline Biétry–Claudet,
Yassine Boukala,
Jean-Luc Gala,
Caroline Bouzin,
Stijn E. Verleden,
Delphine Hoton,
Sophie Gohy,
Bertrand Bearzatto,
Charles Pilette
Affiliations
François M. Carlier
Pole of Pneumology, ENT, and Dermatology, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium; Department of Pneumology, CHU Mont-Godinne UCL Namur, Yvoir, Belgium
Sébastien Dupasquier
Pole of Pneumology, ENT, and Dermatology, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium
Jérôme Ambroise
Centre de Technologies Moléculaires Appliquées, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium
Bruno Detry
Pole of Pneumology, ENT, and Dermatology, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium
Marylène Lecocq
Pole of Pneumology, ENT, and Dermatology, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium
Charline Biétry–Claudet
Pole of Pneumology, ENT, and Dermatology, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium
Yassine Boukala
Pole of Pneumology, ENT, and Dermatology, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium
Jean-Luc Gala
Centre de Technologies Moléculaires Appliquées, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium
Caroline Bouzin
IREC Imaging Platform, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium
Stijn E. Verleden
Lung Transplant Unit, Division of Respiratory Disease, Department of Clinical and Experimental Medicine, Katholieke Universiteit Leuven, Leuven, Belgium
Delphine Hoton
Department of Clinical Laboratory, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Sophie Gohy
Pole of Pneumology, ENT, and Dermatology, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium; Department of Pneumology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Bertrand Bearzatto
Centre de Technologies Moléculaires Appliquées, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium
Charles Pilette
Pole of Pneumology, ENT, and Dermatology, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium; Department of Pneumology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; Corresponding author at: Pole of Pneumology, ENT, and Dermatology, Institute of Experimental and Clinical Research (Université catholique de Louvain), Avenue Mounier, 54 B1.54.04, 1200 Brussels, Belgium
Background: Chronic obstructive pulmonary disease (COPD) is a devastating lung disease, mainly due to cigarette smoking, which represents the third cause of mortality worldwide. The mechanisms driving its epithelial salient features remain largely elusive. We aimed to evaluate the activation and the role of the canonical, β-catenin-dependant WNT pathway in the airway epithelium from COPD patients. Methods: The WNT/β-catenin pathway was first assessed by WNT-targeted RNA sequencing of the air/liquid interface-reconstituted bronchial epithelium from COPD and control patients. Airway expression of total and active β-catenin was assessed in lung sections, as well as WNT components in laser-microdissected airway epithelium. Finally, we evaluated the role of WNT at the bronchial epithelial level by modulating the pathway in the reconstituted COPD epithelium. Findings: We show that the WNT/β-catenin pathway is upregulated in the COPD airway epithelium as compared with that of non-smokers and control smokers, in targeted RNA-sequencing of in vitro reconstituted airway epithelium, and in situ in lung tissue and laser-microdissected epithelium. Extrinsic activation of this pathway in COPD-derived airway epithelium inhibited epithelial differentiation, polarity and barrier function, and induced TGF-β-related epithelial-to-mesenchymal transition (EMT). Conversely, canonical WNT inhibition increased ciliated cell numbers, epithelial polarity and barrier function, whilst inhibiting EMT, thus reversing COPD features. Interpretation: In conclusion, the aberrant reactivation of the canonical WNT pathway in the adult airway epithelium recapitulates the diseased phenotype observed in COPD patients, suggesting that this pathway or its downstream effectors could represent a future therapeutic target. Funding: This study was supported by the Fondation Mont-Godinne, the FNRS and the WELBIO.